Stocks and Investing Stocks and Investing
Wed, June 13, 2018
Tue, June 12, 2018
Mon, June 11, 2018

Yigal Nochomovitz Maintained (ATRA) at Strong Sell with Decreased Target to $575 on, Jun 11th, 2018


Published on 2024-10-26 06:04:37 - WOPRAI, Yigal Nochomovitz
  Print publication without navigation


Yigal Nochomovitz of Citigroup, Maintained "Atara Biotherapeutics, Inc." (ATRA) at Strong Sell with Decreased Target from $625 to $575 on, Jun 11th, 2018.

Yigal has made no other calls on ATRA in the last 4 months.



There is 1 other peer that has a rating on ATRA. Out of the 1 peers that are also analyzing ATRA, 0 agree with Yigal's Rating of Hold.



This is the rating of the analyst that currently disagrees with Yigal


  • Anupam Rama of "JP Morgan" Initiated at Buy on, Tuesday, April 10th, 2018
Contributing Sources